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JNK isoforms control adult mammal hippocampal neurogenesis 
Las isoformas JNK controlan la actividad neurogénica hipocampal adulta en mamíferos  
Rubén D. Castro-Torres a, Oriol Busquets b,c,d,e, Miren Ettcheto b,c,d,e, Antoni Camins b,c,d, Ester 
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Abstract: 
In mammals, the term "Adult Neurogenesis” (AN) defines the process through which, throughout adulthood, new neurons are 
produced from neural stem cells (NSC). These NSC are located in a specific niche, concretely, in the subventricular zone (SVZ), 
lining the lateral ventricles, and in the subgranular zone (SGZ) in the dentate gyrus (DG) of the hippocampus. Controversially, new 
data have questioned the existence of this AN in the human brain seeing how only populations of immature neurons (IN), broadly 
dispersed within SGZ, have been detected. Either way, neurogenic activity in the hippocampus has been correlated with learning, 
memory formation and behavioral responses to stress, just like with the pathophysiology of many brain diseases and mood disorders. 
Various extracellular and intracellular stimuli have been shown to modulate survival, proliferation, and differentiation of adult-born 
cells in the hippocampus, especially through conserved stimuli-response mechanisms like the JNKs. In the present review, the JNK 
pathway and their control of adult hippocampal neurogenesis are described, evidencing the critical role of isoform JNK1.  
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Resumen: 
En mamíferos, el término “Neurogenesis Adulta (NA)”, se define como el proceso a través del cual, en adultos, se producen nuevas 
neuronas granulares a partir de células madre neurales (CMN). Estas CMN estan ubicadas en microambientes específicos, en concreto 
en la zona subventicular (ZSV), recubriendo los ventriculos laterales, y en la zona subgranular (ZSG) del giro dentado del hipocampo 
(GD). Sin embargo, nuevas informaciones han cuestionado la existencia de este proceso de neurogenesis adulta en el cerebro humano, 
ya que solamente se han detectado poblaciones de neuronas inmaduras (NI) dispersas a lo largo de la ZSG. Independientemente, la 
existencia de una actividad neurogénica en el hipocampo adulto se ha correlacionado con el aprendizaje, la formación de memoria y 
en el comportamiento ante situaciones de estrés, así como en la patofisiologia de diferentes patologías del cerebro, incluso en casos 
de alteraciones del estado de ánimo. Se ha demostrado que diferentes estímulos extracelulares e intracelulares controlan la 
supervivencia, la proliferación y la diferenciación de las nuevas neuronas del hipocampo, especialmente a través de mecanismos 
conservados de respuesta a estímulos como las JNKs. En la presente revisión se describe las JNK y su control de la neurogénesis 
hipocampal adulta, evidenciando el papel crucial de la isoforma JNK1. 
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1. GENERAL ASPECTS OF THE JNK PATHWAY. 
JNKs are members of a large group of serine/threonine kinases 
called the mitogen-activated protein kinases (MAPKs). In 
mammals, three genes, Jnk1 (MAPK8), Jnk2 (MAPK9) and Jnk3 
(MAPK10), encode for 10 JNK transcript variants (JNK1α1, 
JNK1α2, JNK1β1, JNK1β2, JNK2α1, JNK2α2, JNK2β1, 
JNK2β2, JNK3α1, JNK3α2) which show differential bodily 
distribution. While JNK1 and JNK2 have ubiquitous tissue 
distribution, JNK3 is only localized in neurons, heart, and testis.1-
3  
On a functional level, the best-described mechanism linked to the 
JNKs is their pro-apoptotic action following sustained or intense 
exposure to cellular stress, such as oxidative, genotoxic and 
osmotic stress or pro-inflammatory cytokines (TNF, Tumor 
necrosis factor; IL-1, interleukin1)5 The JNK pathway has a 
role in many cellular functions linked with human pathologies of 
varying nature: neurodegenerative and autoimmune diseases, 
diabetes, cancer, cardiac hypertrophy, and asthma, among 
others.5-8 Human genetics studies have evidenced that these 
kinases are also involved in the pathophysiology of 
neuropsychiatric disorders.9-11 
Despite their role in disease development, it has also been 
described that basal JNK activity may be important in the central 
nervous system (CNS), both in developmental stages and in 
adulthood in situations of absence of stress. Specifically, in the 
mouse brain, JNK activity has been identified to be 17-fold higher 
compared with peripheral organs.12 Thus, JNKs are key regulators 
of brain morphogenesis and developmental death, neuronal 
migration and pathfinding, axodendritic architecture and synaptic 
plasticity, with a central role in cognitive function, and protein 
transport.13–15 
The JNK pathway is activated following cell exposure to a variety 
of stress events, such as infection, inflammation, oxidative stress, 
DNA damage, osmotic stress, or cytoskeletal changes. Different 
receptors can be activated, including G-protein coupled receptors 
(GPCRs), Wnt receptors, transforming growth factor-β (TGF-β) 
receptors, tumor necrosis factor (TNF) receptors, and the Toll 
receptor complex. Moreover, JNK can be activated in response to 
endoplasmic reticulum stress (ER stress). It has been suggested 
that clustering of cytokine receptors could underlie JNK 
activation in response to UV light or osmotic stress.16 
 
The first member  of the cascade is the MAPK Kinase Kinase 
family (MAPKKKs) that phosphorylates and activates members 
of the MAPK kinase family (MAPKK) which in turn, 
phosphorylate and activate MAPKs (JNK1/SAPK1, 
JNK2/SAPK2, and JNK3/SAPK3) (Figure 1). This sequential 
phosphorylation cascade is facilitated by scaffold JNK-interacting 
proteins (JIP). Post-translation mechanisms, such as acetylation 
and ubiquitination of members of the MAPK cascade can also 
affect MAPK activation, and their inactivation is regulated by 
MAPK phosphatases (MKPs) within a large group of dual-
specificity protein phosphatases (DUSPs) that mediated both 
positive and negative regulation of the MAPK pathway.17-20 
1.1. Substrates of the JNKs. 
Over 100 proteins are substrates of JNKs can be found all over the 
cell. Activated molecules may remain in the cytoplasm, nucleus 
or can be translocated from one compartment to another to exert 
their function. In the nucleus, the JNKs regulate multiple 
transcription factors responsible for gene expression. For 
example, c-Jun, activating transcription factor 2 (ATF2), E26 
transformation-specific-like 1 (Elk-1), p53, nuclear factor of 
activated t-cells 4 (NFAT4) and other chromatin modifiers.17,21,22 
In the cytoplasm, they control microtubule-associated proteins 
such as MAP1B, MAP2, Doublecortin (DCX) and superior 
cervical ganglion 10 protein (SCG10; also known as STMN2), 
phosphatases, cytoskeletal associated protein receptors, 
apoptosis-related proteins, among others (Figure 1).3,17 In 
neurons, specific substrates can be found in dendrites, axons, and 
presynaptic endings.17,22 The existence of all these substrates 
explains the wide range of JNK-controlled biological functions. 
 
1.2. Distribution of the JNKs in the brain. 
The JNK isoforms show divergent distribution patterns in the 
central nervous system (CNS) of mammals. Initial descriptions of 
their localization stated that the Jnk3/SAPK mRNA transcripts 
were the most highly expressed in the rat adult brain, followed by 
Jnk2/SAPKα, mainly located in the neocortex, hippocampus, 
thalamus, and midbrain and finally by Jnk1/SAPK It was 
determined that JNK1 mRNA expression decreased as 
development proceeded, is mainly localized in the endopiriform 
nucleus, medial habenula, and hippocampus. Interestingly, 
Jnk1/SAPK mRNA levels remained high in the plastic olfactory 
area throughout adulthood.23 Controversially, this distribution for 
the Jnk1/SAPK transcripts did not correlate with the results 
obtained in the adult mouse brain by Lee et al., who described 
high immunoreactivity for JNK1/SAPK and JNK3/SAPK in 
most cerebral cortical regions. The authors identified 
JNK3/SAPK isoform in 30% of cortical neurons and 90% of 
hippocampal neurons while JNK1/SAPK isoform was detected 
mainly in CA3 and CA4 hippocampal areas. In the cerebellum, 
they determined high JNK3/SAPK immunoreactivity in the cell 
body of Purkinje cells and granular neurons, while JNK1/SAPK 
was localized in the molecular layer of the cerebellum. Regarding 
JNK2/SAPKα, moderate levels were identified in trigeminal, 
vestibular and facial nuclei of the brain stem and in the deep nuclei 
of the cerebellum.24 
 
The different distribution of the JNK isoforms, together with their 
distinct subcellular localization and the variety of cytosolic and 
nuclear substrates suggest that they may have specific and highly 
varied functions. The use of knockout models has allowed for 
important discoveries, both in understanding better brain 
development25-28, pathologies3,29–32 and the role of the JNKs in 
them. 
 




Figure 1. Representative model of the JNK cascade signaling. MAPK 
signaling is represented as a bow-tie of three different tiers or modules 
in the core of the cascade. These modules represent MAP3K, MAP2K 
and MAPK families. A repertoire of sensory proteins (membrane 
receptors and molecular adapters) receives a variety of stimuli, 
commonly from an extracellular signal in the proximity of the cellular 
membrane activating the MAP3K family. MAP4K is an extra module 
upstream to MAP3K that can be activated by membrane receptors.  
MAP4K is represented by HPK (hematopoietic progenitor kinase); GCK 
(Germinal Center Kinase), GLK (Germinal Center Kinase-Like Kinase),  
HGK (hepatocyte progenitor kinase-like / germinal center kinase-like 
kinase). MAP3Ks are represented by the MLK (the mixed-lineage 
kinase), TAK (transforming growth factor β-activated kinase), ASK 
(apoptosis signal-regulating kinase), MEKKs (MAPK / ERK Kinase 
Kinase) and DLK (Dual Leucine Zipper Kinase) and their different 
isoforms. MAP2K is represented by two members, MKK4 and MKK7. 
MAPK contains only one member and has three different isoforms 
(JNK1, JNK2, and JNK3). JNK phosphorylates microtubule and actin-
associated proteins that regulate migration and the axodendritic 
process.  
 
2. JNKS AND ADULT HIPPOCAMPAL NEUROGENESIS. 
Newborn neurons in the adult hippocampus are necessary to 
maintain normal cognitive functions like learning, memory, and 
adaptation to changing environments. Moreover, several brain 
diseases, such as neurological diseases and mood disorders have 
impaired hippocampal neurogenesis.32,33 Thus, there has been 
continuous effort to study any mechanisms linked to these 
responses, so that new therapeutic strategies that employ 
hippocampal neural stem cells (NSCs) may be developed. Over 
the years, different reports have supported that JNKs have a role 
in the control of adult hippocampal neurogenesis.11,13,34 In the 
present review, it is emphasized the role of JNKs into the control 
of neurogenesis in the hippocampus, with a special focus on 
isoform JNK1.  
 
2.1. Adult neurogenesis in the hippocampus of mammals 
The generation of new neurons from stem and precursor cells in 
the central nervous system (CNS) was believed to occur only 
during embryonic and early postnatal development stages in 
mammals. However, at the beginning of the 20th century, mitotic 
activity in the walls of the lateral ventricle of the adult brain was 
discovered.35 Subsequent studies in young rats demonstrated the 
existence of mitotic cells in the ependymal and subependymal 
layers of the third and lateral ventricles, just like the presence of a 
group of undifferentiated cells near the granular layer (GL) of the 
dentate gyrus (DG) (Figure 2). It was postulated that these 
undifferentiated cells migrate postnatally from the forebrain 
ventricles to the hippocampus where they differentiate.36 
Although the existence of adult hippocampal neurogenesis was 
discovered in 1975 by Joseph Altman, the concept of functional 
hippocampal neurogenesis began to emerge around 1990.37–39 The 
adult neurogenesis process (AN) implies the existence of the 
active stem cells located in specific niches that produce new 
neurons that are subsequently integrated into old circuits through 
life. In mammals, this process is restricted to regions of the 
paleocortex (olfactory bulb, OB), archicortex (hippocampus) and 
the periventricular germinal layer in the hypothalamus.40 
 
Briefly, new neurons are originated from neural stem cells (NSC) 
that extent radial processes and express biomarkers typical of their 
neuroepithelial origin, like the glial fibrillar acidic protein 
(GFAP). Due to these features, NSCs are called radial glia like-
cells (Figure 3A). NSCs proliferate and generate other 
differentiated progenitors with high proliferative capacity (Figure 
3B).41–45 Appropriate stimuli from the environment or internal 
cues stimulate the progress of neuronal NSC determination, 
characterized by the loss of glial-radial projections and the 
expression of DCX, a microtubule-associated protein (Figure 3B, 
C, and D). The second phase is characterized by morphological 
differentiation such as dendritic and axonal extension, spine 
maturation, cessation of mitotic division and migration to the 
granular cell layer and the hilus (Figures 2 and 3).40  
 
Granule cells are the main excitatory neurons of the DG. They 
receive input from the entorhinal cortex and send their axonal 
projection along the mossy fiber tract to pyramidal cells of the 
cornu ammonis 3 (CA3) area. They fire very sparsely and their 
activity is modulated by a large number of interneurons in the DG 
and hilus area.46 
 
It is important to mention that newly-produced cells are not 
destined to fully and continuously replace old granular cells, but 
rather to provide new elements to complete the functional role of 
DG, as it occurs in other tissues (epidermis or bone marrow for 
example). A reduction in the rate of neurogenesis with age is 
correlated with cognitive decline.47 
Biannual Publication, Mexican Journal of Medical Research ICSa, Vol. 8, No. 16 (2020) 5-12 
8 
 
In humans, AN has only been described a few times in the SGZ 
of DG of the hippocampus. One of them was done by Moreno-
Jimenez et al.  who evidenced the presence of immature neurons 
(DCX+) in the DG of humans aged up to 90 years under 
controlled conditions of postmortem tissue fixation.48  Not many 
studies have been able to identify substantial rates of cell 
proliferation or a recognizable niche-like histological 
structure.49,50 This situation has lead to the idea that its existence 
is dubious and debatable even though it is known that this process 
has a prominent role in the maintenance of cognitive function. 





Figure 2. There are two places where the adult neurogenesis occurs in 
rodents, subventricular zone (SVZ) of the lateral ventricles and 
subgranular zone (SGZ) of the granule cell layer of the DG of the 
hippocampus. Progenitors migrate from SVZ to the olfactory bulb (OB) 
forming the rostral migratory stream (RMS). Meanwhile, progenitors 
migrate locally into SGZ through GCL. Sagittal section of a mouse brain  
made by Jonas Töle under license Creative Commons CC0 1.0.  
 
 
Ultimately, the difficulty to identify the AN process in 
hippocampal humans leads to the appearance of different 
interpretations of the nature and function of these 
undifferentiated cells defined as “immature neurons” (IN). For 
now, it seems that they are broadly distributed in the putative 
SGZ (human subgranular area) and hilus, and have a slow rate 
of neuronal maturation, explaining the few proliferative events 
detected in the human hippocampus.40 This theory would imply 
that IN are not newly generated, but rather are static there and 
may replace the adult neurogenic process that occurs in rodents 
and other vertebrates, representing an evolutionary choice in 
large-brained mammals as an alternative form of plasticity.40 
These IN, in addition to being found in the hippocampus, have 
been located in other brain areas like the neocortex and several 
subcortical regions in large-brains.52 
 
Despite these controversies in the existence of clear AN in the 
human hippocampus, a decrease in neurogenesis rate has been 
detected in several pathologies like depression or Alzheimer's 
disease.53 Antidepressant therapy or exercise has been described 
to have a positive effect to ameliorate behavioral phenotypes by 
promoting neurogenic activity.54-56 Specifically, Chohan et al. 
discovered that the peripheral administration in normal adult mice 
of an 11-mer peptide (Peptide 6) designed from an active region 
of the human ciliary neurotrophic factor (CNTF), induced an 
increase of proliferation of neural progenitor cells and their 
differentiation into neurons. These changes were correlated with 
memory affectations.57 Thus, further research must be done to 
determine the presence and roles of hippocampal neurogenesis in 
psychiatric diseases and neurodegenerative disorders. 
 
 
Figure 3. Progenitors from GCL are committed to becoming mature 
granule neurons after experiencing changes in their morphology. First, 
glial radial like-cells (a) progress to immature neurons (b, c, d). 
immature neurons migrate through GCL expressing cellular markers as 
DCX and PSA-NCAM. In the last stages of maturation, immature 
neurons (d) define their axon and dendritic trajectories into the 
hippocampal circuit and gradually lose the expression of immature 
neuron markers and acquire a neuronal phenotype (E). 
 
 
2.2. JNK pathway has a role in the control of adult 
hippocampal neurogenesis. 
Recently, anomalies on the activity of the JNK pathway have been 
associated with alterations in adult hippocampal neurogenesis. 
Sun et al. evidenced that high levels of JNK and p38 
phosphorylation are correlated with a decrease in adult 
hippocampal neurogenesis.56 It was also demonstrated that the 
intrastriatal administration of FAK14, an inhibitor of focal 
adhesion kinase, induced a reduction of phosphorylated JNK 
together with an increase in the neurogenesis in the SVZ. This 
increase was associated with the activation of astrocyte‐derived 
ciliary neurotrophic factor (CNTF). Thus, the FAK–JNK–CNTF 
pathway could be a specific target to promote neurogenesis.58 
In this manner, results obtained in our group support the role of 
JNK in the control of neurogenesis in adult mice. Specifically, in 
Jnk1-/- mice the number of proliferative immature neurons, DCX+ 
cells (Doublecortin) and PSA-NCAM+ cells (Polysialylated 
neuronal cell adhesion molecule) were higher than in WT.34 
Contrarily, the lack of JNK1 induced a decrease in the number of 
early precursor cells34 (glial fibrillary acidic protein, GFAP+, and 
transcription factor Sox2+) as it occurs with the absence of JNK3. 
Altogether, this data supported the idea that these enzymes have a 
role in the adult hippocampal neurogenic activity with a clear 
effect of JNK1 in enhancing the rate of proliferation without 
proper self-renewal, which may promote the extinction of the pool 
of neuronal precursors. Mohamed et al. also observed an increase 
in hippocampal neurogenesis in mice lacking Jnk1. This 
enhancement was characterized by a higher rate in cell 
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proliferation, evaluated with 5-Bromo-2'-deoxyuridine, BrdU (an 
analog of thymidine) cell number and Ki67 positive cell, as 
indicators of cell division; cell survival, analyzing the cell death 
(positive for cleaved caspase-3; cysteine-aspartic acid protease) 
and the increase of immature neurons: DCX+ cells and 
BrdU+/NeuN+ (nuclear antigen used as biomarkers of neurons) 
cells. The same behavioral phenotype that was detected in mice 
lacking JNK1 was observed in mice treated with 
intracerebroventricular infusion of a peptide inhibitor of JNK 
(DJNK1-1, chemically identical to XG-102) that was delivered 
only in immature granule cells, however in this case without an 
increase of hippocampal neurogenesis.11 
All these findings support the idea that JNKs have a role in the 
control of the hippocampal neurogenic niche, specially JNK1 that 
has control in the rate of immature neurons proliferation. This 
effect was supported by the rapid proliferation rate observed in 
embryonic stem cells (ESC) from Jnk1-/- Jnk2-/- mice compared to 
wild type embryonic stem cells. Beside, ESC from Knockout mice 
exhibited alterations in lineage-specific differentiation.59 
Controversially, the opposite effect of JNK1 was observed in 
carcinogenesis. For example, silencing JNK1 by siRNA represses 
the growth of childhood sarcoma, thus indicating that this isoform 
also has a pro-proliferative role; its ablation has also been 
associated with the reduction of lung tumors.60 In this line, mice 
lacking JNK1 exhibited a marked decrease in gastric 
carcinogenesis induced by N-methyl-N-nitrosourea, compared to 
their wild-type counterparts.61 The same occurs with the lack of 
Jnk1 in a mouse hepatocellular carcinoma induced by 
diethylnitrosamine.62 These controversial effects of JNK1 in adult 
hippocampal neurogenic niches and tumor cells may respond to 
the existence of different signal interactions in each environmental 
condition or cell origin. Additionally, the dendritic field size of 
immature granule neurons increased in Jnk1-/- mice, coupled with 
an enhancement in the levels of NR2B, a subunit of the NMDA 
receptors, facilitating synaptic plasticity of newborn neurons.11,63 
Probably these changes can explain the low anxiety phenotype 
observed in Jnk1-/- mice and highlight that the modulation of 
JNK1 activity could be a good strategy for the treatment of 
pathologies like depression or anxiety, just like neurodegenerative 
diseases, stroke, cancer and inflammatory diseases.6,8,64,65 
 
2.3. Regulatory role of JNK signaling in neuronal survival 
and differentiation. 
JNKs besides regulating physiological and pathological processes 
in the central and peripheral nervous system have a critical role in 
the control of neural proliferation, differentiation, viability, and 
structural integrity. All these processes are essential for 
maintaining synaptic connections and neural plasticity. Despite 
having different studies with in vitro models, the role of the JNK 
pathway in these biological processes is still unknown. Here, we 
current knowledge on different substrates of JNKs that may 
control these processes is summarized, just like those additional 
factors that control JNK activity when trying to promote neuronal 
survival and differentiation.65-75  
Mouse embryonic neural stem cells (NSC) were treated with an 
anticonvulsant drug, valproic acid, who induced c-Jun 
phosphorylation by JNK, promoting neuronal differentiation of 
mouse embryonic NSCs and neurite outgrowth of NSC-derived 
neurons. Additionally, the use of a specific JNK inhibitor 
(SP600125), substantially decreased neurite outgrowth of NSC-
derived neurons.66 The treatment with retinoic acid of mouse 
embryonic stem (ES) cells, also supported the role of JNK 
activation in neuronal differentiation. Concretely, through the 
activation of STAT1/3 transcription factors. This JNK effect was 
reinforced with the SP600125 treatment on NSC because the 
neurite outgrowth, during the differentiation and maturation 
stages, was inhibited. Also, this study highlighted the role of 
JNK3 during ESC neuronal commitment and in early neural 
development.67 In another work, with cultures of adult mouse 
dorsal root ganglion (DRG) neurons, it was evidenced that JNK1 
and JNK2 were needed for axonal elongation by regulating the 
phosphorylation state of MAP1B, a cytoskeletal kinase needed for 
sprouting or regenerating axons.68 In the same line, Atkinson et al. 
treated spiral ganglion neurons cultures with neurotrophic factors 
that activated JNK; activation, locally in the growth cones, 
induced neurite outgrowth through the phosphorylation of 
MAP1B and MAP2.69 Using PC12 in vitro neuronal model, Vicki 
et al. reported the role of JNK to promote neuron survival and 
neurite stability through the activation of the transcription factor 
3 (ATF3).70 Treatment of these cells with neurotrophic factors 
revealed that JNK-interacting protein 3 (JIP3) may be involved in 
the transport of vesicular cargo to the growth cones, possible 
targeting JNK to paxillin substrate facilitating neurite 
outgrowth.71 
Adding neurotrophic factor in embryonic sympathetic neurons 
and PC12 cells allowed the identification of Dual-specificity 
protein phosphatases (DUSPs), that selectively dephosphorylates 
JNK, as a key regulator to maintain neuronal survival 
differentiation and synaptic plasticity.72  
 
Moreover, it has been reported that pro-inflammatory cytokines 
who are expressed in diverse neurodegenerative and 
neuroinflammatory conditions have a role in promoting neuronal 
plasticity and cell survival. In this line, the action of the interferon-
gamma (IFN-γ) and tumor necrosis factor-alpha (TNF) in 
enhancing neurite outgrowth of PC12 cells has been evidenced 
after nerve growth factor (NGF) stimuli.73 Concretely, in C17.2 
neural progenitor cells (isolated from the neonatal mouse 
cerebellum), it was elucidated that JNK signaling participates in 
neuronal differentiation in response to IFN-γ.73 Moreover in vivo 
studies with transgenic mice expressing limited amounts of IFN-
γ on the adult brain (levels that not cause gliosis or tissue 
abnormalities) revealed an increase in proliferation and 
differentiation in the dentate gyrus of the hippocampus, associated 
with neuroprotection and improved spatial cognitive 
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performance.74 Despite this effect of IFN-γ in neurogenesis, it 
must be mentioned that its therapeutic benefits would be a 
consequence of the activity of other accompanying cytokines and 
chemokines, both in physiological conditions and in an 
inflammatory response.75 
 
In conclusion, in the present review, it has been evidenced the role 
of the JNK pathway in the control of neuronal proliferation, 
differentiation, and survival, with a special focus on JNK1 in the 
regulation of adult hippocampal neurogenesis in rodents. 
Moreover, the review questions the existence of the adult 
neurogenic process in humans, assuming that in large brains there 
is another form of brain plasticity associated with the presence of 
immature neurons in the hippocampus and also in other brain 
areas. It has also been introduced that adult neurogenesis is altered 
in different diseases. Altogether, the fact that JNKs have a wide 
arrange of possible actions that may vary due to multiple factors, 
makes it essential to continue researching the individual JNKs 
activity so that they can be used as effective therapeutic 
approaches.   
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